0001853373-25-000003.txt : 20250812 0001853373-25-000003.hdr.sgml : 20250812 20250811185031 ACCESSION NUMBER: 0001853373-25-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250812 DATE AS OF CHANGE: 20250811 EFFECTIVENESS DATE: 20250812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kestrel Therapeutics Inc. CENTRAL INDEX KEY: 0001853373 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-554348 FILM NUMBER: 251203415 BUSINESS ADDRESS: STREET 1: 127 WESTERN AVE. CITY: BOSTON STATE: MA ZIP: 02134 BUSINESS PHONE: 617-460-3772 MAIL ADDRESS: STREET 1: 127 WESTERN AVE. CITY: BOSTON STATE: MA ZIP: 02134 D 1 primary_doc.xml X0708 D LIVE 0001853373 Kestrel Therapeutics Inc. Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 617-460-3772 DELAWARE None None Corporation true 2020 Frank G. Haluska Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Executive Officer Director Denis Patrick Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Omar Khalil Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Andrew Phillips Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Nicholas Saccomano Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Barbara Sosnowski Attn: Pagliuca Harvard Life Lab 127 Western Ave. Boston MA MASSACHUSETTS 02134 Director Biotechnology Decline to Disclose 06b false 2025-07-28 false true true true false 0 10000000 5000000 5000000 false 6 0 0 0 false Kestrel Therapeutics Inc. /s/Frank G. Haluska Frank G. Haluska President and Chief Executive Officer 2025-08-11